Nexilico Inc Profile last edited on: 3/17/2020
CAGE: 7YGZ9
UEI: Z2H3SNX8WJ36
Business Identifier: Next generation computational tools for microbiome precision medicine 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 12
County: Alameda
Congr. District: 12
County: Alameda
Public Profile
Nexilico Inc. is developing next generation computational tools for microbiome precision medicine.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 1 | NIH | $275,765 | |
| Project Title: Novel probiotics to mitigate xenobiotic toxicity through microbial biotransformation | ||||
| 2023 | 2 | NSF | $1,224,995 | |
| Project Title: An omics-based computational platform for the personalization of gut microbiome therapeutics | ||||
| 2022 | 1 | NIH | $380,000 | |
| Project Title: Computational prediction of gut microbiome-mediated drug metabolism | ||||
| 2019 | 1 | NIH | $224,929 | |
| Project Title: A Predictive Computational Platform for Gut Microbiome Precision Medicine | ||||
Key People / Management
Mohammad Soheilypour
Company News
There are no news available.
